LAVENTATUG TIVEDOTIN
UNII NUK386L57F

Substance Identification & Data

This profile provides standardized clinical and technical data for Laventatug Tivedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NUK386L57F.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3009829-96-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NUK386L57F
CAS Registry Number
3009829-96-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LAVENTATUG TIVEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13521
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Laventatug Tivedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LAVENTATUG TIVEDOTIN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN ZINC TRANSPORTER ZIP6) (HUMAN-MUS MUSCULUS MONOCLONAL BRY812 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN-MUS MUSCULUS MONOCLONAL BRY812 .KAPPA.-CHAIN, DIMER, 219'',223,229,232-TETRAKIS(THIOETHER) WITH N-METHYL-N-(((4-((N-(2-MERCAPTOACETYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
LAVENTATUG TIVEDOTIN [INN]